Stock Watch: Contrasting Novartis And J&J Stock Movements Defy Explanation
Strong Dollar Should Not Be Overlooked In Q2 Results
Among equity investors there is concern about the impact of macroeconomic headwinds on second-quarter earnings. The first two big life sciences companies’ reports did nothing to alleviate those concerns.
